The ginger component 6-shogaol prevents TNF-α-induced barrier loss via inhibition of PI3K/Akt and NF-κB signaling

Mol Nutr Food Res. 2016 Dec;60(12):2576-2586. doi: 10.1002/mnfr.201600274. Epub 2016 Sep 16.

Abstract

Scope: Anti-inflammatory properties of the ginger-derived pungent component 6-shogaol (6-SG) have been studied intensively in recent years. Purpose of this study was to characterize the influence of 6-SG on inflammation-related intestinal barrier dysfunction, especially its paracellular component.

Methods and results: The effect of 6-SG was studied in the human intestinal cell models HT-29/B6 and Caco-2 either under control conditions or challenged by the pro-inflammatory cytokine tumor necrosis factor α (TNF-α). Electrophysiological measurements, freeze-fracture electron microscopy, and protein analyses were performed. 6-SG partially prevented both, the TNF-α-induced decrease in transepithelial resistance and the rise in fluorescein permeability. By inhibiting phosphatidylinositol-3-kinase/Akt signaling 6-SG prevented the TNF-α-induced increase in protein expression of claudin-2, a channel-forming tight junction protein. In addition, the TNF-α-induced disassembly of the sealing tight junction protein claudin-1 was attenuated, the latter of which was due to TNF-α-triggered phosphorylation of nuclear factor kappa light chain enhancer of activated B cells (NF-κB).

Conclusion: 6-SG has barrier-protective effects by affecting TNF-α-induced claudin-2 upregulation and claudin-1 disassembly via inhibition of phoshatidylinositol-3-kinase/Akt and nuclear factor kappa light chain enhancer of activated B-cell signaling. Therefore, 6-SG-containing food might be beneficial for barrier preservation during intestinal inflammation.

Keywords: 6-Shogaol; Ginger; Intestinal barrier; TNF-α; Tight junction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents / pharmacology*
  • B-Lymphocytes / metabolism
  • Caco-2 Cells
  • Catechols / pharmacology*
  • Claudin-1 / genetics
  • Claudin-1 / metabolism
  • Claudins / genetics
  • Claudins / metabolism
  • HT29 Cells
  • Humans
  • Intestines / cytology
  • Intestines / drug effects
  • NF-kappa B / genetics
  • NF-kappa B / metabolism*
  • Phosphatidylinositol 3-Kinases / genetics
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Signal Transduction / drug effects*
  • Tight Junctions / drug effects
  • Tight Junctions / metabolism
  • Tumor Necrosis Factor-alpha / pharmacology
  • Up-Regulation
  • Zingiber officinale / chemistry*

Substances

  • Anti-Inflammatory Agents
  • CLDN1 protein, human
  • CLDN2 protein, human
  • Catechols
  • Claudin-1
  • Claudins
  • NF-kappa B
  • Tumor Necrosis Factor-alpha
  • shogaol
  • Phosphatidylinositol 3-Kinases